To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The search for a treatment for ...
・The company’s bacteriophage therapy AP-SA02 achieved an 88% response rate in a Phase 2a trial for Staphylococcus aureus bacteremia, with no relapses reported. ・H.C. Wainwright reiterated a ‘Buy’ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results